SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-16-461251
Filing Date
2016-02-12
Accepted
2016-02-12 09:07:30
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d140185dsc13ga.htm SC 13G/A 29713
  Complete submission text file 0001193125-16-461251.txt   31448
Mailing Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 750 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Subject) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88106 | Film No.: 161414721
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AVALON MANAGEMENT LTD, LANDMARK SQ 1ST FLOOR, P.O. BOX 715, 64 EARTH CLOSE GRAND CAYMAN E9 KY1-1107
Business Address C/O AVALON MANAGEMENT LTD, LANDMARK SQ 1ST FLOOR, P.O. BOX 715, 64 EARTH CLOSE GRAND CAYMAN E9 KY1-1107 41(55)5 111 222
aeris Capital Equity Investments, L.P. (Filed by) CIK: 0001605431 (see all company filings)

IRS No.: 981113056 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A